Freeline Therapeutics Holdings plc FRLN

$ 6.48 0.0%

Annual report 2022
added 11-09-2024

Freeline Therapeutics Holdings plc Financial Statements 2011-2024 | FRLN

Annual Financial Statements Freeline Therapeutics Holdings plc

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	261 M	44.3 M	255 M	40.1 M	20.3 M	-	-	-	-	-	-	-
Shares	59.3 M	35.7 M	14.2 M	6.35 M	4.62 M	-	-	-	-	-	-	-
Historical Prices	4.4	1.24	18	-	-	-	-	-	-	-	-	-
Net Income	-89 M	-140 M	-96.3 M	-53.9 M	-33.3 M	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-98.4 M	-142 M	-102 M	-63.6 M	-41 M	-	-	-	-	-	-	-
Interest Expense	-	-165 K	-9.29 M	-793 K	7.72 M	-	-	-	-	-	-	-
EBITDA	-96.7 M	-140 M	-101 M	-62.1 M	-40 M	-	-	-	-	-	-	-
Operating Expenses	-	142 M	-	63.6 M	41 M	-	-	-	-	-	-	-
General and Administrative Expenses	-	44.6 M	26.3 M	16.6 M	6.79 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Freeline Therapeutics Holdings plc

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	-	-	-	42.6 M	35.9 M	35.8 M	35.8 M	35.7 M	35.9 M	-	11.9 M	9.01 M	12 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-	-	-	-26.7 M	-	-	-	-34.9 M	-	-	-	-16.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-	-	-28.2 M	-	-	-	-33.9 M	-	-	-	-21.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	990 K	-	-	-	-1.73 M	-	-	-	863 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-27.6 M	-	-	-	-33.4 M	-	-	-	-20.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	28.2 M	-	-	-	33.9 M	-	-	-	21.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	-	-	-	8.22 M	-	-	-	10.1 M	-	-	-	3.74 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency